One thing that became clear very quickly this past year was that the COVID-19 pandemic would change the way we deliver care to patients. What has not changed amid an evolving healthcare landscape is our driving focus to ensure our patients’ access to rheumatology care and the availability of state-of-the-art treatments. We know you share…
Introduced in the Senate on Feb. 25, the bill would amend the Employee Retirement Income Security Act to provide a clear process and circumstances for requesting medical exceptions to step therapy protocols.
The 2019 event, to be held Sept. 9-10 in Washington, D.C., will bring together rheumatology professionals and patients to advocate on behalf of the rheumatology community.
The ACR recently issued three new position statements on key issues facing rheumatologists and patients with rheumatic diseases: step therapy, affordable prescription drug pricing and a special waived test designation for synovial fluid crystal analysis performed by rheumatologists. Here is a detailed look at each. Addressing Step Therapy Step therapy or fail first protocols require patients…